Finance & Acquisitions

Trulieve Cannabis Corp. has received approval to list on the New York Stock Exchange beginning June 10 under ticker symbol TRLV. Marking a historic shift for U.S. plant-touching operators, the company paved its path to the major exchange by executing a strategic corporate restructuring to maintain a 100-percent medical consolidated footprint following federal Schedule III reclassification.

High revenue might catch a buyer’s eye, but it takes more than just strong numbers to close a deal. As federal reclassification reshapes the cannabis industry, acquirers are looking beyond EBITDA to determine a business's true worth. Here are the hidden operational drivers that maximize a dispensary’s valuation and help build a highly scalable, premium acquisition target.

Expanding your cannabis operation is an exciting milestone, but it’s also the exact moment your bank starts paying closer attention. Every new license, state, or investor changes your company's risk profile in the eyes of financial institutions. If left unmanaged, this newfound complexity can unexpectedly put your banking relationships in jeopardy. Two bankers reveal the hidden risks of rapid expansion, why your bank suddenly has so many questions, and how to successfully scale your business without losing access to crucial financial services.

The historic federal shift reclassifying medical marijuana to Schedule III brings undeniable progress, offering long-awaited tax relief from Section 280E. Yet, despite the initial market excitement, rescheduling is not a cure-all for the industry’s deep-rooted liquidity crisis. Cash buyers remain scarce, transactions rely heavily on seller financing, and regulatory fragmentation persists. True competitive advantage in a mature market won’t come from waiting on Washington. It will come from corporate architecture. Here’s why some cannabis operators are looking past policy hype and leveraging independent buyouts to achieve the ultimate business goal: a tax-free exit.

In a move that signals massive consolidation in the B2B events space, Apollo Global Management has agreed to acquire Emerald Holding Inc. — parent company of MJBizCon — in a $1.5-billion all-cash deal. The transaction will take the publicly traded Emerald private, merging its portfolio with Questex LLC to create a unified experiential media platform. While the deal reflects Apollo’s broader interest in specialized markets rather than a specific cannabis play, the shift raises critical questions about the future of the industry’s largest trade show. Will MJBizCon thrive under new institutional ownership, or drift within a larger, more diverse portfolio?

For years, cannabis operators believed a “clean” compliance record was the finish line for banking stability. Yet, even businesses that clear every regulatory hurdle still face sudden account closures and restricted capital. The reality of 2026 is that compliance alone no longer guarantees a seat at the table. To secure lower capital costs and durable lending relationships, the industry must move toward “bankability” — a sophisticated trust layer built on real-time transparency. Meeting regulatory checkboxes is just the entry requirement; deep financial signals are the new standard for long-term operational survival.

AI arrived wearing a suit, and cannabis arrived wearing tie-dye. It’s time we talk about why American capital is more responsive to costume than risk.

Paybotic Financial is offering a limited-time 420 Banking Special for cannabis operators. Qualified businesses can access compliant, FDIC-insured banking with no monthly maintenance fees for up to 18 months.

Following a series of SEC penalties, executive shifts, and a failed bid to go private, Weedmaps’ parent company prepares to transition to the OTC Markets.

GTI’s new $70 million annual payment to RYTHM is the latest twist in a longer story of brand transfers, debt, and overlapping leadership.